Zobrazeno 1 - 10
of 767
pro vyhledávání: '"mucosal adjuvanticity"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hiroki Uchiyama, Toshifumi Kudo, Takehiro Yamaguchi, Nozomu Obana, Kenji Watanabe, Kimihiro Abe, Hidetaka Miyazaki, Masanori Toyofuku, Nobuhiko Nomura, Yukihiro Akeda, Ryoma Nakao
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThere is a growing interest in development of novel vaccines against respiratory tract infections, due to COVID-19 pandemic. Here, we examined mucosal adjuvanticity and the mucosal booster effect of membrane vesicles (MVs) of a novel probioti
Externí odkaz:
https://doaj.org/article/f9ac0a5cea9a47029ede47ea185d23ea
Autor:
Kawamura, Hanae, Yoshino, Naoto, Murakami, Kazuyuki, Kawamura, Hideki, Sugiyama, Ikumi, Sasaki, Yutaka, Odagiri, Takashi, Sadzuka, Yasuyuki, Muraki, Yasushi
Publikováno v:
In European Journal of Pharmaceutics and Biopharmaceutics January 2023 182:1-11
Autor:
Yoshino, Naoto, Kawamura, Hanae, Sugiyama, Ikumi, Sasaki, Yutaka, Odagiri, Takashi, Sadzuka, Yasuyuki, Muraki, Yasushi
Publikováno v:
In European Journal of Pharmaceutics and Biopharmaceutics August 2021 165:113-126
Autor:
Hanae Kawamura, Naoto Yoshino, Kazuyuki Murakami, Hideki Kawamura, Ikumi Sugiyama, Yutaka Sasaki, Takashi Odagiri, Yasuyuki Sadzuka, Yasushi Muraki
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 182:1-11
The relationship between the chemical structure, physicochemical properties, and mucosal adjuvanticity of sugar-based surfactants (SBSs) has not been sufficiently elucidated. Thus, in the present study, we systematically analyzed 11 SBSs for mucosal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d61d6df6d3dd894d9bd63e8b2bc6c178
https://doi.org/10.1016/j.ejpb.2022.11.023
https://doi.org/10.1016/j.ejpb.2022.11.023
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Naoto Yoshino, Ryosuke Takeshita, Hanae Kawamura, Yutaka Sasaki, Masahiro Kagabu, Toru Sugiyama, Yasushi Muraki, Shigehiro Sato
Publikováno v:
Immunity, Inflammation and Disease, Vol 6, Iss 1, Pp 117-127 (2018)
Abstract Introduction Surfactin (SF) is a cyclic lipopeptide that has potent mucosal adjuvant properties. However, immunological mechanisms of SF adjuvant action have not yet been elucidated. As some cyclic lipopeptides, such as polymyxin, can stimul
Externí odkaz:
https://doaj.org/article/db5a2ecf8a3545eea95726557cc65609
Autor:
Uchiyama, Hiroki, Kudo, Toshifumi, Yamaguchi, Takehiro, Obana, Nozomu, Watanabe, Kenji, Abe, Kimihiro, Miyazaki, Hidetaka, Toyofuku, Masanori, Nomura, Nobuhiko, Akeda, Yukihiro, Nakao, Ryoma
Publikováno v:
Human Vaccines & Immunotherapeutics; December 2024, Vol. 20 Issue: 1
Autor:
Mee-Sun Kim, Eun-Je Yi, Young-In Kim, So Hee Kim, Yi-Sook Jung, Seong-Ryeol Kim, Takao Iwawaki, Hyun-Jeong Ko, Sun-Young Chang
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Cholera toxin (CT) is one of most strong mucosal adjuvants, but it cannot be clinically used owing to its toxicity. The cytosolic A1 subunit of CT (CTA1) is the molecule responsible for its immunostimulatory activity, which increases the concentratio
Externí odkaz:
https://doaj.org/article/ac26a4a106114d09a8ee66efb3323a3d
Autor:
Yoshino, Naoto1 nyoshino@iwate-med.ac.jp, Takeshita, Ryosuke2, Kawamura, Hanae2, Sasaki, Yutaka1, Kagabu, Masahiro2, Sugiyama, Toru2, Muraki, Yasushi1, Sato, Shigehiro1
Publikováno v:
Immunity, Inflammation & Disease. Mar2018, Vol. 6 Issue 1, p117-127. 11p.